Search research articles
Contact Us
Filters
Showing results (181-190 of 235) with videos related to
Page
of 24
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2020
Geographic and Ethnic Heterogeneity of Germline <i>BRCA1</i> or <i>BRCA2</i> Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the POLO Trial
Talia Golan, Hedy L Kindler, Joon Oh Park, et al.
The Oncologist
|
November 8, 2025
Fertility preservation practices and gastrointestinal oncologist in Europe: a pan-European study
Irit Ben-Aharon, Tal Goshen-Lago, Alberto Puccini, et al.
Oncology Research and Treatment
|
September 17, 2024
Guidelines of Onkopedia: What Is New? Locally Advanced Rectal Cancer
Ralf-Dieter Hofheinz, Dirk Arnold, Markus Borner, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
October 17, 2023
German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer
Florian Lordick, Salah-Eddin Al-Batran, Dirk Arnold, et al.
Cancer Treatment Reviews
|
June 15, 2021
Treatment breaks in first line treatment of advanced colorectal cancer: An individual patient data meta-analysis
Richard Adams, Kaitlyn Goey, Benoist Chibaudel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 10, 2024
Efficacy and Safety of the Anti-IL1RAP Antibody Nadunolimab (CAN04) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Advanced/Metastatic Pancreatic Cancer
Eric Van Cutsem, Joelle Collignon, Rikke L Eefsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 12, 2011
Biomarkers for cetuximab-based neoadjuvant radiochemotherapy in locally advanced rectal cancer
Peter P Grimminger, Peter Danenberg, Kathrin Dellas, et al.
Cardiovascular and Interventional Radiology
|
February 6, 2024
Factors Impacting Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: A Combined Analysis of the Prospective CIRT Studies
Peter Reimer, Valérie Vilgrain, Dirk Arnold, et al.
The Lancet. Oncology
|
September 13, 2015
Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial
Susanna Hegewisch-Becker, Ullrich Graeven, Christian A Lerchenmüller, et al.
The Lancet. Oncology
|
November 22, 2012
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
Jaafar Bennouna, Javier Sastre, Dirk Arnold, et al.
Page
of 24
Search research articles
Search
Showing results (181-190 of 235) with videos related to
Sort By:
Page
of 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2020
Geographic and Ethnic Heterogeneity of Germline <i>BRCA1</i> or <i>BRCA2</i> Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the POLO Trial
Talia Golan, Hedy L Kindler, Joon Oh Park, et al.
The Oncologist
|
November 8, 2025
Fertility preservation practices and gastrointestinal oncologist in Europe: a pan-European study
Irit Ben-Aharon, Tal Goshen-Lago, Alberto Puccini, et al.
Oncology Research and Treatment
|
September 17, 2024
Guidelines of Onkopedia: What Is New? Locally Advanced Rectal Cancer
Ralf-Dieter Hofheinz, Dirk Arnold, Markus Borner, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
October 17, 2023
German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer
Florian Lordick, Salah-Eddin Al-Batran, Dirk Arnold, et al.
Cancer Treatment Reviews
|
June 15, 2021
Treatment breaks in first line treatment of advanced colorectal cancer: An individual patient data meta-analysis
Richard Adams, Kaitlyn Goey, Benoist Chibaudel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 10, 2024
Efficacy and Safety of the Anti-IL1RAP Antibody Nadunolimab (CAN04) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Advanced/Metastatic Pancreatic Cancer
Eric Van Cutsem, Joelle Collignon, Rikke L Eefsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 12, 2011
Biomarkers for cetuximab-based neoadjuvant radiochemotherapy in locally advanced rectal cancer
Peter P Grimminger, Peter Danenberg, Kathrin Dellas, et al.
Cardiovascular and Interventional Radiology
|
February 6, 2024
Factors Impacting Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: A Combined Analysis of the Prospective CIRT Studies
Peter Reimer, Valérie Vilgrain, Dirk Arnold, et al.
The Lancet. Oncology
|
September 13, 2015
Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial
Susanna Hegewisch-Becker, Ullrich Graeven, Christian A Lerchenmüller, et al.
The Lancet. Oncology
|
November 22, 2012
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
Jaafar Bennouna, Javier Sastre, Dirk Arnold, et al.
Page
of 24